Acetoxy Empagliflozin CAS: 915095-99-7
| Helu Helu | XD93612 |
| inoa mea kūʻai | ʻO Acetoxy Empagliflozin |
| CAS | 915095-99-7 |
| ʻAno Molekalala | C31H35ClO11 |
| Kaumaha Molekala | 619.06 |
| Nā kikoʻī mālama | Ambient |
Huahana Huahana
| Ka nana aku | Pauda keʻokeʻo |
| ʻO Assay | 99% min |
ʻO Acetoxy Empagliflozin, i kapa ʻia ʻo empagliflozin acetate, he ʻano hoʻololi o ka lāʻau antidiabetic empagliflozin.Aia ʻo Empagliflozin i kahi papa o nā lāʻau i kapa ʻia ʻo sodium-glucose co-transporter 2 (SGLT2) inhibitors, i hoʻohana mua ʻia no ka mālama ʻana i ka maʻi diabetes type 2. Hana ʻo Empagliflozin ma ke kāohi ʻana i ka SGLT2, kahi protein e kuleana no ka hoʻihoʻi ʻana i ka glucose i loko o nā puʻupaʻa.Ma ka pale ʻana i kēia protein, hoʻoikaika ka empagliflozin i ka excretion o ka glucose ma o ka mimi, e alakaʻi ana i ka hoʻohaʻahaʻa ʻana i ke kiʻekiʻe o ka glucose i ke koko i nā poʻe me ka maʻi diabetes.Ke manaʻo nei kēia hoʻololi e hoʻonui i ka paʻa a me ka bioavailability o ka lāʻau lapaʻau, hiki ke alakaʻi i ka hoʻomaikaʻi ʻana i nā hopena therapeutic.Ke lawe ʻia ma ka waha, hana ia ma ka hōʻemi ʻana i ka reabsorption glucose renal, ka hopena i ka hoʻonui ʻana i ka glucose urinary.Kōkua kēia ʻano hana e hoʻohaʻahaʻa i ka pae glucose koko a hoʻomaikaʻi i ka mana glycemic i nā poʻe maʻi me ka maʻi maʻi type 2. Ma waho aʻe o kāna mau hopena hoʻohaʻahaʻa glucose, ua hōʻike ʻia nā mea hoʻopaneʻe SGLT2 e like me Acetoxy Empagliflozin i nā pono lua.Hoʻopili kēia i nā hoʻomaikaʻi ʻana i nā hopena cardiovascular, e like me ka hōʻemi ʻana i ka hopena o ka make ʻana o ka maʻi cardiovascular, ka pau ʻole o ka naʻau, a me ka hahau ʻana.Hiki iā lākou ke alakaʻi i ka pohō kaumaha, hoʻohaʻahaʻa i ke kiʻekiʻe o ke koko, a hōʻemi i ka pono o ka insulin a i ʻole nā lāʻau lapaʻau antidiabetic ʻē aʻe. ketoacidosis.Ua kuhikuhi pinepine ʻia me ka hoʻololi ʻana i ke ʻano o ka nohona, me ka ʻai a me ka hoʻomaʻamaʻa ʻana, e ʻoi aku ka maikaʻi o ka mālama ʻana i ka maʻi maʻi. .He mea koʻikoʻi ia no ka poʻe e lawe ana i kēia lāʻau lapaʻau e nānā pono i ko lākou pae glucose koko a hōʻike i nā hopena pili i kā lākou mea mālama ola.Hoʻohana ia ma ke ʻano he SGLT2 inhibitor, e kōkua ana i ka hoʻohaʻahaʻa ʻana i ke kiʻekiʻe o ka glucose koko i nā maʻi me ka maʻi diabetes type 2 ma o ka hoʻonui ʻana i ka urine glucose excretion.Hiki iā ia ke hāʻawi i nā pono ʻē aʻe, e like me nā pono cardiovascular a me ke kaumaha.Eia naʻe, e like me nā lāʻau lapaʻau, he mea nui e hahai i ke alakaʻi a ke kauka mālama olakino a nānā pono i nā hopena ʻaoʻao.
